(Q38542515)

4 September 2017

1 reference

title

Fecal Microbiota Transplant: Treatment Options for Clostridium difficile Infection in the Intensive Care Unit (English)

1 reference

4 September 2017

0 references

Clostridium difficile

0 references

author name string

Samuel Han

series ordinal

1

1 reference

4 September 2017

Sarah Shannahan

series ordinal

2

1 reference

4 September 2017

Randall Pellish

series ordinal

3

1 reference

4 September 2017

publication date

3 July 2015

1 reference

Journal of Intensive Care Medicine

4 September 2017

published in

1 reference

4 September 2017

volume

31

1 reference

4 September 2017

issue

9

1 reference

4 September 2017

page(s)

577-586

1 reference

Clinical practice. Antibiotic-associated diarrhea

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Review of current literature on the economic burden of Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Clostridium difficile--more difficult than ever

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

An epidemic, toxin gene-variant strain of Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Clostridium difficile infection: epidemiology, risk factors and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Recommendations for surveillance of Clostridium difficile-associated disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Duodenal infusion of donor feces for recurrent Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Fecal transplantation: re-discovering the value of stool

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Toxin B is essential for virulence of Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Clostridium difficile toxins: mechanism of action and role in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Clostridium difficile colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

The role of toxin A and toxin B in Clostridium difficile-associated disease: Past and present perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Human Hypervirulent Clostridium difficile Strains Exhibit Increased Sporulation as Well as Robust Toxin Production

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

21 January 2018

Colonization resistance

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Nosocomial acquisition of Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Clostridium difficile colonization and diarrhea at a tertiary care hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Clinical prediction rules to optimize cytotoxin testing for Clostridium difficile in hospitalized patients with diarrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Utility of perirectal swab specimens for diagnosis of Clostridium difficile infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

The utility of repeated stool toxin testing for diagnosing Clostridium difficile colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Repeat stool testing to diagnose Clostridium difficile infection using enzyme immunoassay does not increase diagnostic yield.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Evaluation of repeat Clostridium difficile enzyme immunoassay testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Clinical manifestations, treatment and control of infections caused by Clostridium difficile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Clostridium difficile ribotype 027, toxinotype III, the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Evaluation of diagnostic tests for Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Evaluation of the diagnostic performance of the xpert Clostridium difficile assay and its comparison with the toxin A/B enzyme-linked fluorescent assay and in-house real-time PCR assay used for the detection of toxigenic C. difficile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Evaluation of the C.Diff Quik Chek Complete Assay, a new glutamate dehydrogenase and A/B toxin combination lateral flow assay for use in rapid, simple diagnosis of clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Evaluation of a loop-mediated isothermal amplification assay for diagnosis of Clostridium difficile infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Rapid and sensitive loop-mediated isothermal amplification test for Clostridium difficile detection challenges cytotoxin B cell test and culture as gold standard

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Loop-mediated isothermal amplification compared to real-time PCR and enzyme immunoassay for toxigenic Clostridium difficile detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Comparison of Illumigene, Simplexa, and AmpliVue Clostridium difficile molecular assays for diagnosis of C. difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Systematic review: Clostridium difficile and inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Impact of Clostridium difficile on inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Predictors of mortality after colectomy for fulminant Clostridium difficile colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Surgical aspects of fulminant Clostridium difficile colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Outcomes of emergency colectomy for fulminant Clostridium difficile colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

In vitro activities of OPT-80 and comparator drugs against intestinal bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

In vitro activity of OPT-80 against Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

In vitro activity of OPT-80 tested against clinical isolates of toxin-producing Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Fidaxomicin versus vancomycin for Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Fidaxomicin therapy in critically ill patients with Clostridium difficile infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

In vitro activity of rifaximin, metronidazole and vancomycin against Clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic and aerobic bacteria, including ammonia-producing species

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Efficacy of rifaximin and vancomycin combination therapy in a patient with refractory Clostridium difficile-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Rifaximin Is Effective for the Treatment of Clostridium difficile-Associated Diarrhea: Results of an Open-Label Pilot Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Rifaximin for the treatment of recurrent Clostridium difficile infection after liver transplantation: A case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

The epidemiology of community-acquired Clostridium difficile infection: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Policy: How to regulate faecal transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

American Journal of Gastroenterology Lecture: Intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C. difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Fecal microbiota transplantation for fulminant Clostridium difficile infection in an allogeneic stem cell transplant patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Faecal microbiota transplantation for severe Clostridium difficile infection in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Fecal transplant against relapsing Clostridium difficile-associated diarrhea in 32 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Toward an understanding of changes in diversity associated with fecal microbiome transplantation based on 16S rRNA gene deep sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Success of self-administered home fecal transplantation for chronic Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Relapsing clostridium difficile enterocolitis cured by rectal infusion of homologous faeces

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Fecal microbiome transplantation for recurrent Clostridium difficile infection: report on a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Fecal bacteriotherapy for relapsing Clostridium difficile infection in a child: a proposed treatment protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Efficacy of combined jejunal and colonic fecal microbiota transplantation for recurrent Clostridium difficile Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Resolution of severe Clostridium difficile infection following sequential fecal microbiota transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

Host and Pathogen Factors forClostridium difficileInfection and Colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066615594344

21 January 2018

Identifiers

DOI

10.1177/0885066615594344

1 reference

4 September 2017

1 reference